Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
12
HERB Quote, Financials, Valuation and Earnings
Last price:
$0.0500
Seasonality move
:
30.26%
Day range:
$0.0500 - $0.0500
52-week range:
$0.0241 - $0.2200
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.01x
P/B ratio:
0.04x
Volume:
--
Avg. volume:
15.2K
1-year change:
16.28%
Market cap:
$7.9M
Revenue:
--
EPS (TTM):
--
| Period Ending | 2011-12-31 | 2012-12-31 | 2013-12-31 | 2014-12-31 | 2015-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $949.1M | $993.1M | $1B | $1B | $938.9M | |
| Revenue Growth (YoY) | 11.73% | 4.63% | 1.84% | 0.08% | -7.24% | |
| Cost of Revenues | $827.5M | $859.9M | $867.8M | $869.3M | $819.7M | |
| Gross Profit | $121.6M | $133.2M | $143.5M | $142.9M | $119.2M | |
| Gross Profit Margin | 12.81% | 13.41% | 14.19% | 14.11% | 12.69% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $6M | $6.5M | $6.7M | $5.9M | $6.1M | |
| Other Inc / (Exp) | $687.9K | $885.8K | $688.1K | $686.4K | $654.3K | |
| Operating Expenses | $6M | $6.5M | $6.7M | $5.9M | $6.1M | |
| Operating Income | $115.6M | $126.6M | $136.7M | $136.9M | $113.1M | |
| Net Interest Expenses | $2.2M | $1.1M | $937.2K | $666.6K | $573.2K | |
| EBT. Incl. Unusual Items | $114.1M | $126.4M | $136.5M | $136.9M | $111.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | $114.1M | $126.4M | $136.5M | $136.9M | $111.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $114.1M | $126.4M | $136.5M | $136.9M | $111.9M | |
| Basic EPS (Cont. Ops) | $0.74 | $0.82 | $0.88 | $0.88 | $0.71 | |
| Diluted EPS (Cont. Ops) | $0.74 | $0.82 | $0.88 | $0.88 | $0.71 | |
| Weighted Average Basic Share | $155.1M | $155.1M | $155.1M | $155.1M | $157.2M | |
| Weighted Average Diluted Share | $155.1M | $155.1M | $155.1M | $155.1M | $157.2M | |
| EBITDA | $125.6M | $138.5M | $150.5M | $150.5M | $126.8M | |
| EBIT | $116.3M | $127.5M | $137.4M | $137.6M | $112.4M | |
| Revenue (Reported) | $949.1M | $993.1M | $1B | $1B | $938.9M | |
| Operating Income (Reported) | $115.6M | $126.6M | $136.7M | $136.9M | $113.1M | |
| Operating Income (Adjusted) | $116.3M | $127.5M | $137.4M | $137.6M | $112.4M | |
| Period Ending | 2011-12-31 | 2012-12-31 | 2013-12-31 | 2014-12-31 | 2015-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $295.6M | $300.9M | $323.4M | $303.6M | $229.3M | |
| Revenue Growth (YoY) | 16.26% | 1.78% | 7.5% | -6.14% | -24.48% | |
| Cost of Revenues | $255.8M | $256.9M | $270.5M | $252.9M | $204.2M | |
| Gross Profit | $39.8M | $44M | $52.9M | $50.6M | $25M | |
| Gross Profit Margin | 13.46% | 14.61% | 16.36% | 16.68% | 10.91% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2M | $2.3M | $2.4M | $1.6M | $1.7M | |
| Other Inc / (Exp) | -$2.6K | $23.4K | $21.1K | -$1.1M | $186.8K | |
| Operating Expenses | $2M | $2.3M | $2.4M | $1.6M | $1.7M | |
| Operating Income | $37.7M | $41.6M | $50.5M | $49.1M | $23.3M | |
| Net Interest Expenses | $331.9K | $25.8K | $189.7K | $516.2K | -- | |
| EBT. Incl. Unusual Items | $37.4M | $41.6M | $50.4M | $47.4M | $22.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | $37.4M | $41.6M | $50.4M | $47.4M | $22.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $37.4M | $41.6M | $50.4M | $47.4M | $22.2M | |
| Basic EPS (Cont. Ops) | $0.25 | $0.27 | $0.32 | $0.30 | $0.14 | |
| Diluted EPS (Cont. Ops) | $0.25 | $0.27 | $0.32 | $0.30 | $0.14 | |
| Weighted Average Basic Share | $155.1M | $155.1M | $155.1M | $155.1M | $157.2M | |
| Weighted Average Diluted Share | $155.1M | $155.1M | $155.1M | $155.1M | $157.2M | |
| EBITDA | $40.1M | $44.9M | $55.9M | $51.2M | $27.2M | |
| EBIT | $37.7M | $41.6M | $50.5M | $47.9M | $22.2M | |
| Revenue (Reported) | $295.6M | $300.9M | $323.4M | $303.6M | $229.3M | |
| Operating Income (Reported) | $37.7M | $41.6M | $50.5M | $49.1M | $23.3M | |
| Operating Income (Adjusted) | $37.7M | $41.6M | $50.5M | $47.9M | $22.2M | |
| Period Ending | 2011-12-31 | 2012-12-31 | 2013-12-31 | 2014-12-31 | 2015-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $949.1M | $993.1M | $1B | $1B | $938.9M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $827.5M | $859.9M | $867.8M | $869.3M | $819.7M | |
| Gross Profit | $121.6M | $133.2M | $143.5M | $142.9M | $119.2M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $6M | $6.5M | $6.7M | $5.9M | $6.1M | |
| Other Inc / (Exp) | $687.9K | $365.1K | $171.3K | -$2M | $194.2K | |
| Operating Expenses | $6M | $6.5M | $6.7M | $5.9M | $6.1M | |
| Operating Income | $115.6M | $126.6M | $136.7M | $136.9M | $113.1M | |
| Net Interest Expenses | $2.2M | $1.1M | $937.2K | $666.6K | $573.2K | |
| EBT. Incl. Unusual Items | $114.1M | $126.4M | $136.5M | $136.9M | $111.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | $126.4M | $136.5M | $136.9M | $111.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $114.1M | $126.4M | $136.5M | $136.9M | $111.9M | |
| Basic EPS (Cont. Ops) | $0.75 | $0.81 | $0.86 | $0.88 | $0.71 | |
| Diluted EPS (Cont. Ops) | $0.75 | $0.81 | $0.86 | $0.88 | $0.71 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | $125.6M | $138.5M | $150.5M | $151.6M | $129M | |
| EBIT | $116.3M | $127.5M | $137.5M | $138.6M | $112.6M | |
| Revenue (Reported) | $949.1M | $993.1M | $1B | $1B | $938.9M | |
| Operating Income (Reported) | $115.6M | $126.6M | $136.7M | $136.9M | $113.1M | |
| Operating Income (Adjusted) | $116.3M | $127.5M | $137.5M | $138.6M | $112.6M | |
| Period Ending | 2020-12-23 | 2021-12-23 | 2022-12-23 | 2023-12-23 | ||
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2011-12-31 | 2012-12-31 | 2013-12-31 | 2014-12-31 | 2015-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $10.7M | $11M | $11.3M | $11.9M | $1.4M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $80.4M | $91.9M | $103.1M | $112.1M | $876.8K | |
| Inventory | $140.5M | $227.3M | $319M | $341.8M | $1.3M | |
| Prepaid Expenses | -- | -- | $4.4M | $4.1M | $2.8M | |
| Other Current Assets | $4.3M | $4M | -- | -- | -- | |
| Total Current Assets | $235.9M | $334.1M | $437.8M | $469.8M | $118.2M | |
| Property Plant And Equipment | $769.6M | $792.6M | $855.8M | $912.2M | $39.4M | |
| Long-Term Investments | $203.9K | $204.4K | $210.7K | $209.9K | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $1.1B | $1B | $1.1B | $1.1B | $100.7M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $2.1B | $2.2B | $2.4B | $2.5B | $258.3M | |
| Accounts Payable | $41M | $25.1M | $31.5M | $27.4M | $17.4K | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $6.4M | $4.9M | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $779.5K | $726.8K | $12.5M | $9.8M | $22.6K | |
| Total Current Liabilities | $62.2M | $41.1M | $44M | $37.2M | $99.4K | |
| Long-Term Debt | $2.3M | -- | $24.6M | $21.1M | $45.7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $98.4M | $69.2M | $68.5M | $58.2M | $45.8M | |
| Common Stock | $155.1M | $155.1M | $155.1M | $155.1M | $157.2M | |
| Other Common Equity Adj | $383.1M | $388.4M | $443.4M | $446M | -$56.5M | |
| Common Equity | $2B | $2.1B | $2.3B | $2.4B | $212.6M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $2B | $2.1B | $2.3B | $2.4B | $212.6M | |
| Total Liabilities and Equity | $2.1B | $2.2B | $2.4B | $2.5B | $258.3M | |
| Cash and Short Terms | $10.7M | $11M | $11.3M | $11.9M | $1.4M | |
| Total Debt | $21.7M | $14.5M | $24.6M | $21.1M | $45.7M | |
| Period Ending | 2011-12-31 | 2012-12-31 | 2013-12-31 | 2014-12-31 | 2015-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $10.7M | $11M | $11.3M | $11.9M | $1.4M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $80.4M | $91.9M | $103.1M | $112.1M | $876.8K | |
| Inventory | $140.5M | $227.3M | $319M | $341.8M | $1.3M | |
| Prepaid Expenses | $4.3M | $4M | $4.4M | $4.1M | $2.8M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $235.9M | $334.1M | $437.8M | $469.8M | $118.2M | |
| Property Plant And Equipment | $769.6M | $792.6M | $855.8M | $912.2M | $39.4M | |
| Long-Term Investments | $203.9K | $204.4K | $210.7K | $209.9K | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $1.1B | $1B | $1.1B | $1.1B | $100.7M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $2.1B | $2.2B | $2.4B | $2.5B | $258.3M | |
| Accounts Payable | $41M | $25.1M | $31.5M | $27.4M | $17.4K | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $779.5K | $726.8K | $12.5M | $9.8M | $22.6K | |
| Total Current Liabilities | $62.2M | $41.1M | $44M | $37.2M | $99.4K | |
| Long-Term Debt | $2.3M | -- | $24.6M | $21.1M | $45.7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $98.4M | $69.2M | $68.5M | $58.2M | $45.8M | |
| Common Stock | $155.1M | $155.1M | $155.1M | $155.1M | $157.2M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $2B | $2.1B | $2.3B | $2.4B | $212.6M | |
| Total Liabilities and Equity | $2.1B | $2.2B | $2.4B | $2.5B | $258.3M | |
| Cash and Short Terms | $10.7M | $11M | $11.3M | $11.9M | $1.4M | |
| Total Debt | $21.7M | $14.5M | $24.6M | $21.1M | $45.7M | |
| Period Ending | 2011-12-31 | 2012-12-31 | 2013-12-31 | 2014-12-31 | 2015-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $114.1M | $126.4M | $136.5M | $136.9M | $111.9M | |
| Depreciation & Amoritzation | $9.3M | $10.9M | $13.1M | $12.9M | $14.4M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$301.6K | -$11.8M | -$8.8M | -$18.6M | -$111.2M | |
| Change in Inventories | -$31.6M | -$86.5M | -$84.7M | -$60.3M | $340.5M | |
| Cash From Operations | $86M | $23.7M | $51.1M | $68.1M | $321M | |
| Capital Expenditures | $77.6M | $11.1M | $43.8M | $61.9M | $324.3M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$77.6M | -$11.1M | -$43.8M | -$61.9M | -$324.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $5.3M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -$5.9M | -$4.4M | -$3.4M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $9.3M | -- | -- | -- | -- | |
| Cash From Financing | $9.9M | -$13.2M | -$8.4M | -$5.9M | $2.1M | |
| Beginning Cash (CF) | $10.1M | $10.7M | $11M | $11.3M | $11.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$1.6M | -$622.6K | -$1M | $256.3K | -$1.2M | |
| Ending Cash (CF) | $10.7M | $11M | $11.3M | $11.9M | $1.4M | |
| Levered Free Cash Flow | $8.4M | $12.6M | $7.3M | $6.2M | -$3.3M | |
| Period Ending | 2011-12-31 | 2012-12-31 | 2013-12-31 | 2014-12-31 | 2015-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $37.4M | $41.6M | $50.4M | $47.4M | $22.2M | |
| Depreciation & Amoritzation | $2.4M | $3.2M | $5.3M | $3.3M | $5M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$42K | -$8.2M | -$2.3M | -$8.5M | -$98M | |
| Change in Inventories | -$18.8M | -$26.9M | -$22M | -$16.4M | $382.9M | |
| Cash From Operations | $20.6M | -$2.6M | $31M | $24.8M | $278.3M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$18M | -$283.7K | -$30.9M | -$25M | -$285.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$748.5K | -$4.1M | -$667.9K | -$1.8M | $2.7M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $4.6M | -- | -- | -- | -- | |
| Cash From Financing | $9.1M | -$4.1M | -$667.9K | -$1.8M | $4.8M | |
| Beginning Cash (CF) | $10.6M | $16.9M | $11.2M | $13.5M | $11.5M | |
| Foreign Exchange Rate Adjustment | -$958K | $1.2M | $636K | $415.8K | -$7.2M | |
| Additions / Reductions | $1.1M | -$7.1M | -$537.5K | -$2M | -$2.8M | |
| Ending Cash (CF) | $10.7M | $11M | $11.3M | $11.9M | $1.4M | |
| Levered Free Cash Flow | $20.6M | -$2.6M | $31M | $24.8M | $278.3M | |
| Period Ending | 2011-12-31 | 2012-12-31 | 2013-12-31 | 2014-12-31 | 2015-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | $126.4M | $136.5M | $136.9M | $111.9M | |
| Depreciation & Amoritzation | $9.3M | $10.9M | $13.1M | $12.9M | $14.4M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$301.6K | -$11.8M | -$8.8M | -$18.6M | -$111.2M | |
| Change in Inventories | -$31.6M | -$86.5M | -$84.7M | -$60.3M | $340.5M | |
| Cash From Operations | $86M | $23.7M | $51.1M | $68.1M | $321M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$77.6M | -$11.1M | -$43.8M | -$61.9M | -$324.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$4.6M | -$13.2M | -$8.4M | -$5.9M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $656.5K | -$13.2M | -$8.4M | -$5.9M | $2.1M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$1.6M | -$622.6K | -$1M | $256.3K | -$1.2M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $86M | $23.7M | $51.1M | $68.1M | $321M | |
| Period Ending | 2020-12-23 | 2021-12-23 | 2022-12-23 | 2023-12-23 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get HERB Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
HERB
Sector
P/E ratio
--
17.73x
PEG ratio
--
0.35x
P/B ratio
0.04x
1.67x
Price / LTM sales
0.01x
0.69x
Growth Metrics
HERB
Sector
Revenue growth
--
0.27%
Earnings growth
--
-3.16%
Revenue (5-year growth)
--
4.3%
Earnings forecast
--
$0.31
Profitability
HERB
Sector
Profitability FY 2024
--
$575.2M
Return on invested capital
--
5.51%
Return on assets
--
3.55%
Return on equity
--
8.37%
Earnings Date
Last Earnings Date
Dec
23
Next Earnings Date
Dec
23
Estimated Next Earnings Date
Mar
24
Balance Sheet
HERB
Sector
Total cash
--
$163.2M
Short term investments
--
$53.7M
Total assets
--
$1.9B
Long term debt
--
$145.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 7.65% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 11.85% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 0.5% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
